Depression patient-derived cortical neurons reveal potential biomarkers for antidepressant response
Introduction Major depressive disorder is highly prevalent worldwide and has been affecting an increasing number of people each year. Current first line antidepressants show merely 37% remission, and physicians are forced to use a trial-and-error approach when choosing a single antidepressant out...
Main Authors: | Y. Avior, S. Ron, D. Kroitorou, E. Nitzan, B. Corneo, D. Laifenfeld, T. Cohen Solal |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2021-04-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933821003928/type/journal_article |
Similar Items
-
Depression patient-derived cortical neurons reveal potential biomarkers for antidepressant response
by: Yishai Avior, et al.
Published: (2021-04-01) -
Patient iPSC-derived neurons reveal mechanisms underlying antidepressant response: a potential diagnostic tool
by: S. Shohat Koren, et al.
Published: (2023-03-01) -
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
by: Catarina Correia, et al.
Published: (2022-08-01) -
Proteomic biomarkers of depression
by: Tang Li, et al.
Published: (2022-04-01) -
A comparative study of personality aspects of females with depression using the antidepressant medications: selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs)
by: Saeed Pournaghash tehrani, et al.
Published: (2018-03-01)